Shareholders Equity: The sum of preferred and common equity items.
Molecular Partners AG Sponsored ADR (MOLN) had Shareholders Equity of $129.30M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-24.73M |
|
$12.98M |
|
$-12.98M |
|
$20.99M |
|
$-20.99M |
|
$-3.73M |
|
$-24.73M |
|
$-24.73M |
|
$-24.73M |
|
$-24.73M |
|
$-24.73M |
|
$-24.73M |
|
$-20.99M |
|
$-20.27M |
|
36.42M |
|
36.42M |
|
$-0.68 |
|
$-0.68 |
|
| Balance Sheet Financials | |
$146.15M |
|
$4.46M |
|
$4.47M |
|
$150.62M |
|
$15.63M |
|
-- |
|
$5.69M |
|
$21.32M |
|
$129.29M |
|
$129.28M |
|
|
Shareholders Equity |
$129.30M |
37.39M |
|
| Cash Flow Statement Financials | |
$-36.58M |
|
$60.53M |
|
$-0.66M |
|
$77.43M |
|
$99.37M |
|
$21.94M |
|
$2.87M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.35 |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-37.24M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-19.12% |
|
-19.13% |
|
-16.42% |
|
-19.12% |
|
$3.46 |
|
$-1.02 |
|
$-1.00 |
|